EGF
Image Gallery
[ (||image_reduire{0,60}|inserer_attribut{alt,EGF signaling pathways}) ]The epidermal growth factor (EGF) peptide induces cellular proliferation through the EGF receptor, which has a tyrosine kinase cytoplasmic domain, a single transmembrane domain and an extracellular domain involved in EGF binding and receptor dimerization.
Inhibitors of the EGF receptor are being pursued as potential cancer therapies and EGF may stimulate wound healing.
The proliferative effects of EGF are signaled through several pathways.
Binding of EGF results in EGF receptor dimerization, autophosphorylation of the receptor, and tyrosine phosphorylation of other proteins.
The EGF receptor activates ras and the MAP kinase pathway, ultimately causing phosphorylation of transcription factors such as c-Fos to create AP-1 and ELK-1 that contribute to proliferation.
Activation of STAT-1 and STAT-3 transcription factors by JAK kinases in response to EGF contributes to proliferative signaling.
Phosphatidylinositol signaling and calcium release induced by EGF activate protein kinase C, another component of EGF signaling.
Crosstalk of EGF signaling with other pathways make the EGF receptor a junction point between signaling systems.
(From Biocarta)
References
Citri A, Yarden Y. EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol. 2006 Jul;7(7):505-16. PMID: #16829981#